MARKET

RKDA

RKDA

Arcadia
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.150
+0.080
+3.86%
After Hours: 2.150 0 0.00% 16:00 09/28 EDT
OPEN
2.060
PREV CLOSE
2.070
HIGH
2.240
LOW
2.060
VOLUME
469.12K
TURNOVER
--
52 WEEK HIGH
6.40
52 WEEK LOW
1.990
MARKET CAP
47.67M
P/E (TTM)
30.85
1D
5D
1M
3M
1Y
5Y
BRIEF-Arcadia Biosciences Announces Leadership Transition
reuters.com · 09/07 21:14
Arcadia Biosciences Launches Search For New CEO, Current COE Matt Plavan To Step Down Once Successor Named
Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that it has launched a national search for a new Chief Executive Officer as
Benzinga · 09/07 20:17
18 Stocks Moving in Tuesday's Pre-Market Session
Gainers Regional Health Properties Inc (NYSE: RHE) rose 50.3% to $12.49 in pre-market trading after jumping over 15% on Monday. The company, earlier during the month, reported Q2 results.
Benzinga · 08/31 11:33
Jay-Z-Backed The Parent Co. Revenue Grows 18.9% YoY To $54.2M In Second Quarter
TPCO Holding Corp. (NEO: GRAM.U) (OTCQX: GRAMF), which does business as The Parent Company, announced its second-quarter financial results on Monday, revealing net sales of $54.2 million, representing approximately 18.9% growth compared to the adjusted Q1 ...
Benzinga · 08/17 12:58
BRIEF-Arcadia Biosciences - In Q2 Of 2021, Revenues Were $1.4 Million, Compared To Revenues Of $281,000 In Q2 Of 2020
reuters.com · 08/16 21:36
Arcadia Biosciences Q2 Net Loss $5.261M vs $9.689M In Same Qtr. Last Year, Sales $1.41M Miss $1.71M Estimate
Arcadia Biosciences (NASDAQ:RKDA) reported quarterly sales of $1.41 million which missed the analyst consensus estimate of $1.71 million by 17.84 percent. This is a 400.00 percent increase over sales of $281.00 thousand
Benzinga · 08/16 20:22
The Parent Company Reports Second Quarter 2021 Financial Results
COMTEX_391667428/2669/2021-08-16T16:05:39
CNW Group · 08/16 20:05
-- Earnings Flash (RKDA) ARCADIA BIOSCIENCES Reports Q2 Revenue $1.4M
MT Newswires · 08/16 16:24
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of RKDA. Analyze the recent business situations of Arcadia through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average RKDA stock price target is 6.23 with a high estimate of 7.18 and a low estimate of 4.500.
High7.18
Average6.23
Low4.500
Current 2.150
EPS
Actual
Estimate
-0.260.080.420.76
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Institutional Holdings
Institutions: 39
Institutional Holdings: 2.72M
% Owned: 12.25%
Shares Outstanding: 22.17M
TypeInstitutionsShares
Increased
8
613.04K
New
11
1.17M
Decreased
4
32.03K
Sold Out
6
408.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Agricultural Chemicals
-0.46%
Chemicals
-1.54%
Key Executives
Chairman/Director
Kevin Comcowich
Chief Executive Officer/Director
Matthew Plavan
Chief Financial Officer
Pamela Haley
Chief Marketing Officer
Laura Pitlik
Vice President - Operations
Belinda Yao
Vice President
Tracy Baker
Vice President
Donald Emlay
Vice President
Kevin Hodges
Other
Zhongjin Lu
Other
Sarah Reiter
Director
Jamie Bechtel
Director
Albert Bolles
Director
Debbie Carosella
Director
Peter Gajdos
Director
Lilian Shackleford Murray
Director
Gregory Waller
Director
Amy Yoder
No Data
About RKDA
Arcadia Biosciences, Inc is engaged in developing crop improvements. The Company develops crops in wheat, soy and hemp, designed for farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products for industrial applications. It uses breeding techniques to develop. The Company's GoodWheat product ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Its GoodHemp seed catalog delivers hemp seeds, transplants and extracts. It offers Sonova GLA Safflower Oil by growing safflower plants producing seed which are high in gamma-linolenic acid (GLA). It also offers its Sonova GLA as a nutritional additive to adult dry dog and cat food formulations.

Webull offers kinds of Arcadia Biosciences Inc stock information, including NASDAQ:RKDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RKDA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RKDA stock methods without spending real money on the virtual paper trading platform.